187 related articles for article (PubMed ID: 3667780)
1. High-performance liquid chromatographic assay for the experimental anticancer agent oxantrazole.
Frank SK; Mathiesen DA; Whitfield LR; Ames MM
J Chromatogr; 1987 Aug; 419():225-32. PubMed ID: 3667780
[TBL] [Abstract][Full Text] [Related]
2. High-performance liquid chromatographic analysis of the anticancer drug oxantrazole in rat whole blood and tissues.
Hassan EE; Gallo JM
J Chromatogr; 1992 Nov; 582(1-2):225-31. PubMed ID: 1491045
[TBL] [Abstract][Full Text] [Related]
3. Preclinical pharmacology of the anthrapyrazole analog oxantrazole (NSC-349174, piroxantrone).
Frank SK; Mathiesen DA; Szurszewski M; Kuffel MJ; Ames MM
Cancer Chemother Pharmacol; 1989; 23(4):213-8. PubMed ID: 2924379
[TBL] [Abstract][Full Text] [Related]
4. Detection and separation of the anthrapyrazole CI-941 and its metabolites in serum and urine by high-performance liquid chromatography.
Proksch B; Blanz J; Zeller KP; Ehninger G
J Chromatogr B Biomed Appl; 1994 Aug; 658(2):349-53. PubMed ID: 7820263
[TBL] [Abstract][Full Text] [Related]
5. Development of a radioimmunoassay for the anthrapyrazole chemotherapy agent CI-937 and the pharmacokinetics of CI-937 in rats.
Nordblom GD; Pachla LA; Chang T; Whitfield LR; Showalter HD
Cancer Res; 1989 Oct; 49(19):5345-51. PubMed ID: 2766301
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a highly rapid and sensitive LC-MS/MS method for determination of SZ-685C, an investigational marine anticancer agent, in rat plasma--application to a pharmacokinetic study in rats.
Chen JY; Wang XD; Zhong GP; Qin XL; Li JL; Huang ZY; Zhu X; Li MF; Huang M
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2127-34. PubMed ID: 21703949
[TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatographic assay and preclinical pharmacological studies of pibenzimol (bisbenzimidazole).
Ames MM; Miller KJ; Moertel DM
J Chromatogr; 1985 May; 341(1):89-96. PubMed ID: 2410440
[TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatographic determination of pyrazoloacridine, a nitro-9-methoxyacridine anticancer agent, in human plasma.
Jayewardene AL; Santoro JE; Gambertoglio JG
J Chromatogr B Biomed Sci Appl; 1997 Nov; 702(1-2):203-10. PubMed ID: 9449572
[TBL] [Abstract][Full Text] [Related]
9. Specific high-performance liquid chromatographic assay with ultraviolet detection for the determination of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea in plasma.
Supko JG; Phillips LR; Malspeis L
J Chromatogr B Biomed Appl; 1996 Mar; 677(2):351-62. PubMed ID: 8704941
[TBL] [Abstract][Full Text] [Related]
10. Liquid chromatographic procedure for the quantitative analysis of carboplatin in beagle dog plasma ultrafiltrate.
Duncan GF; Faulkner HC; Farmen RH; Pittman KA
J Pharm Sci; 1988 Mar; 77(3):273-6. PubMed ID: 3286860
[TBL] [Abstract][Full Text] [Related]
11. Determination of the arotinoid mofarotene in human, rat and dog plasma by high-performance liquid chromatography with automated column switching and ultraviolet detection.
Wyss R; Bucheli F; Hess B
J Chromatogr A; 1996 Apr; 729(1-2):315-22. PubMed ID: 9004956
[TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatographic assay for CI-980, a novel 1-deaza-7,8-dihydropteridine anticancer agent, in human plasma and urine.
Bullen WW; Whitfield LR; Walter GA; Brodfuehrer JI
J Chromatogr B Biomed Appl; 1995 Jun; 668(1):141-51. PubMed ID: 7550971
[TBL] [Abstract][Full Text] [Related]
13. Determination of 5,10,15,20-tetra-(m-hydroxyphenyl)chlorin in human plasma by high performance liquid chromatography.
Wang Q; Ris HB; Altermatt HJ; Reynolds B; Stewart JC; Bonnett R; Lim CK
Biomed Chromatogr; 1993; 7(1):45-7. PubMed ID: 8431680
[TBL] [Abstract][Full Text] [Related]
14. Determination of the novel topoisomerase I inhibitor NU/ICRF 505 and its major metabolite in plasma, tissue and tumour by high-performance liquid chromatography.
Cummings J; Meikle I; Macpherson JS; Smyth JF
J Chromatogr B Biomed Appl; 1996 Oct; 685(1):159-64. PubMed ID: 8930764
[TBL] [Abstract][Full Text] [Related]
15. Ion-paired high-performance liquid chromatographic determination of mitoxantrone in physiological fluids.
van Belle SJ; Schoemaker TJ; Verwey SL; Paalman AC; McVie JG
J Chromatogr; 1985 Jan; 337(1):73-80. PubMed ID: 3980659
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a high-performance liquid chromatographic method for bioanalytical application with rimonabant.
Bhaumik U; Ghosh A; Chatterjee B; Sengupta P; Darbar S; Roy B; Nandi U; Pal TK
J Pharm Biomed Anal; 2009 May; 49(4):1009-13. PubMed ID: 19250788
[TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatographic assay for genistein in biological fluids.
Supko JG; Phillips LR
J Chromatogr B Biomed Appl; 1995 Apr; 666(1):157-67. PubMed ID: 7655614
[TBL] [Abstract][Full Text] [Related]
18. Optimisation of a reversed-phase high-performance liquid chromatographic method for the determination of flavone acetic acid and its major human metabolites in plasma and urine.
Cummings J; Kerr DJ; Kaye SB; Smyth JF
J Chromatogr; 1988 Sep; 431(1):77-85. PubMed ID: 3235538
[TBL] [Abstract][Full Text] [Related]
19. Determination of ethylenediamineplatinum(II) malonate in infusion fluids, human plasma and urine by high-performance liquid chromatography.
van der Vijgh WJ; Elferink F; Postma GJ; Vermorken JB; Pinedo HM
J Chromatogr; 1984 Oct; 310(2):335-42. PubMed ID: 6511851
[TBL] [Abstract][Full Text] [Related]
20. Quantification of a novel retinoic acid metabolism inhibitor, 4-(1H-imidazol-1-yl)retinoic acid (VN/14-1RA) and other retinoids in rat plasma by liquid chromatography with diode-array detection.
Wu C; Njar V; Brodie A; Borenstein M; Nnane I
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):203-8. PubMed ID: 15380716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
